These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2928579)

  • 1. Psychotropic drug use in older developmentally disabled with behavioral difficulties.
    Harper DC; Wadsworth JS; Michael AL
    Res Dev Disabil; 1989; 10(1):53-60. PubMed ID: 2928579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral problems and medication utilization.
    Harper DC; Wadsworth JS
    Ment Retard; 1993 Apr; 31(2):97-103. PubMed ID: 8479337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations in the use of psychotropic drugs in elderly mentally retarded persons.
    Aman MG
    J Ment Defic Res; 1990 Feb; 34 ( Pt 1)():1-10. PubMed ID: 2182880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic and anticonvulsant drug use by mentally retarded adults across community residential and vocational placements.
    Martin JE; Agran M
    Appl Res Ment Retard; 1985; 6(1):33-49. PubMed ID: 2859836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotropic drugs and mental retardation: 1. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings.
    Clarke DJ; Kelley S; Thinn K; Corbett JA
    J Ment Defic Res; 1990 Oct; 34 ( Pt 5)():385-95. PubMed ID: 2266549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopharmacoepidemiology of mental retardation: 1966 to 1995.
    Singh NN; Ellis CR; Wechsler H
    J Child Adolesc Psychopharmacol; 1997; 7(4):255-66. PubMed ID: 9542696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment with psychotropic drugs in various facilities for mentally handicapped patients].
    Meins W; Auwetter J; Krausz M; Turnier Y
    Nervenarzt; 1993 Jul; 64(7):451-5. PubMed ID: 8103571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication and programming in controlling the behavior of mentally retarded individuals in community settings.
    Schalock RL; Foley JW; Toulouse A; Stark JA
    Am J Ment Defic; 1985 Mar; 89(5):503-9. PubMed ID: 2859807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic-based pharmacological treatment of behavior disorders in persons with developmental disabilities: a review and a decision-making typology.
    Sturmey P
    Res Dev Disabil; 1995; 16(4):235-52. PubMed ID: 7480954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of psychotropic medications for persons with mental retardation who live in Oklahoma nursing homes.
    Spreat S; Conroy J
    Psychiatr Serv; 1998 Apr; 49(4):510-2. PubMed ID: 9550242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication use among Australian adults with intellectual disability in primary healthcare settings: a cross-sectional study.
    Doan TN; Lennox NG; Taylor-Gomez M; Ware RS
    J Intellect Dev Disabil; 2013 Jun; 38(2):177-81. PubMed ID: 23550741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapse of aggressive and disruptive behavior in mentally retarded adults following antipsychotic drug withdrawal predicts psychotropic drug use a decade later.
    Janowsky DS; Barnhill LJ; Khalid AS; Davis JM
    J Clin Psychiatry; 2006 Aug; 67(8):1272-7. PubMed ID: 16965207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and drug use in mentally retarded, emotionally disturbed adults.
    Matson JL; Kazdin AE; Senatore V
    Appl Res Ment Retard; 1984; 5(4):513-9. PubMed ID: 6151823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dementia and depression in elders with mental retardation: a pilot study.
    Harper DC; Wadsworth JS
    Res Dev Disabil; 1990; 11(2):177-98. PubMed ID: 2142796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personality disorder in mental handicap.
    Reid AH; Ballinger BR
    Psychol Med; 1987 Nov; 17(4):983-7. PubMed ID: 3432470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
    Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
    BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmentally disabled, doubly disadvantaged.
    Parker G
    Med J Aust; 1991 Jul; 155(2):68-71. PubMed ID: 1857308
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychotropic medication use for adults and older adults with intellectual disability; selective review, recommendations and future directions.
    Deutsch SI; Burket JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110017. PubMed ID: 32544599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotropic drug treatment among learning-disabled, educable mentally retarded, and seriously emotionally disturbed students.
    Cullinan D; Gadow KD; Epstein MH
    J Abnorm Child Psychol; 1987 Dec; 15(4):469-77. PubMed ID: 3437084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability. A total population study.
    Bowring DL; Totsika V; Hastings RP; Toogood S; McMahon M
    J Intellect Disabil Res; 2017 Jun; 61(6):604-617. PubMed ID: 28090687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.